Jepsen S, Hansen A B
Department of Anesthesiology and Intensive Care, Odense University Hospital, Denmark.
Scand J Clin Lab Invest. 1994 Nov;54(7):543-7. doi: 10.3109/00365519409088566.
The purpose of the study was to evaluate whether the infusion of N-acetylcysteine decreased the measurement of prothrombin time and activated partial thromboplastin time (APTT) in healthy persons. N-acetylcysteine was administered intraveneously 10 mg kg-1 as a loading dose and then at a rate of 10 mg kg-1 h-1 for 32 h in six male subjects. The intrinsic, extrinsic and common pathway of coagulation were monitored with activated partial thromboplastin time (APTT), and prothrombin time, respectively. In addition, the extrinsic coagulation pathway was monitored with the clotting activity of single factors II, VII, and X. No effect on the intrinsic coagulation pathway was observed. There was a significant and rapid decrease in prothrombin time. Coagulation factors II, VII and X, the three components of prothrombin time, decreased significantly to different degrees. We conclude that infusion of N-acetylcysteine intraveneously decreases the prothrombin time in healthy subjects. Thus, one should not make conclusions which are too far-reaching based on prothrombin time alone in patients who have been treated recently with N-acetylcysteine intraveneously.
该研究的目的是评估静脉输注N-乙酰半胱氨酸是否会降低健康人的凝血酶原时间及活化部分凝血活酶时间(APTT)的测定值。对6名男性受试者静脉注射10 mg/kg的N-乙酰半胱氨酸作为负荷剂量,然后以10 mg·kg-1·h-1的速率持续输注32小时。分别采用活化部分凝血活酶时间(APTT)和凝血酶原时间监测凝血的内源性、外源性及共同途径。此外,通过单一因子II、VII和X的凝血活性监测外源性凝血途径。未观察到对内源性凝血途径有影响。凝血酶原时间出现显著且快速的降低。凝血酶原时间的三个组成成分,即凝血因子II、VII和X,均有不同程度的显著降低。我们得出结论,静脉输注N-乙酰半胱氨酸会降低健康受试者的凝血酶原时间。因此,对于近期接受过静脉注射N-乙酰半胱氨酸治疗的患者,不应仅基于凝血酶原时间得出过于牵强的结论。